NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve management of malignant melanoma using adjuvant therapy. After hearing and assimilating this program, the clinician will be better able to:
1. Compare the efficacy and safety of targeted therapy and checkpoint immunotherapy for adjuvant treatment of high-risk melanoma.
2. Explain the rationale for adjuvant therapy in stage II melanoma.
3. Summarize upcoming and future developments for the management of malignant melanoma.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2022-12-13 06:00:00
- End Date: 2022-12-13 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest